CCN3 and glioma: EGFR, BCAN, SOX2, PTN and CCN3 were found to be highly elevated in the glioma tumorous tissue with prominent fold change value, while other DE-ARGs, such as CLU, SCG3, showed no distinct expression alteration (Fig. 7b).